Western blotting indicated that FASN was expressed at different levels in all three breast cancer cell lines; FASN expression was higher in HER2-positive cells, such as SKBR3 and MCF-7/HER2 cells, than in MCF-7 cells, which expressed lower HER2 levels. Here, ERBB2 is linked to breast carcinoma.